US2015197499A1PendingUtilityA1

Hepatitis C Virus Inhibitors

Assignee: BRISTOL MYERS SQUIBB COPriority: Nov 11, 2009Filed: Mar 25, 2015Published: Jul 16, 2015

Est. expiryNov 11, 2029(~3.3 yrs left)· nominal 20-yr term from priority

Inventors:Rico Lavoie John A. Bender Zhong Yang Makonen Belema Omar D. Lopez Qi Chen Gan Wang Piyasena Hewawasam

A61P 31/14A61P 43/00A61P 1/16C07D 413/14A61K 31/4178A61K 45/06C07D 401/14C07D 403/10A61K 38/21A61K 31/4184A61K 31/4709C07D 471/04C07D 209/54A61K 31/5377C07D 487/04C07D 405/14A61K 31/4545A61K 31/4375A61K 31/4985A61K 31/437A61K 2300/00C07D 403/14C07D 309/06A61K 31/498

PatentIndex Score

Cited by

References

Claims

Abstract

The present disclosure relates to compounds, compositions and methods for the treatment of Hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

Claims

exact text as granted — not AI-modified

What is claimed is: 
     
         1 . A compound which is 
       
         
           
           
               
               
           
         
         or a pharmaceutically acceptable salt thereof.

Join the waitlist — get patent alerts

Track US2015197499A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.